Beijing Bohui Innovation Biotechnology Group Co (SZSE:300318) Capital Expenditure : ¥-204.82 Mil (TTM As of Mar. 2024)

View and export this data going back to 2012. Start your Free Trial

What is Beijing Bohui Innovation Biotechnology Group Co Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Beijing Bohui Innovation Biotechnology Group Co's cash flow for capital expenditures for the three months ended in Mar. 2024 was ¥-73 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-204.82 Mil.

Beijing Bohui Innovation Biotechnology Group Co Capital Expenditure Historical Data

The historical data trend for Beijing Bohui Innovation Biotechnology Group Co's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Bohui Innovation Biotechnology Group Co Capital Expenditure Chart

Beijing Bohui Innovation Biotechnology Group Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Capital Expenditure

Get a 7-Day Free Trial

-108.87

-202.33

-367.06

-161.46

-197.55

Beijing Bohui Innovation Biotechnology Group Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Capital Expenditure	Get a 7-Day Free Trial															-65.39	-43.24	-48.49	-40.43	-72.67

Beijing Bohui Innovation Biotechnology Group Co Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-204.82 Mil.

Beijing Bohui Innovation Biotechnology Group Co (SZSE:300318) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Beijing Bohui Innovation Biotechnology Group Co Ltd (SZSE:300318) » Definitions » Capital Expenditure

Comparable Companies

Traded in Other Exchanges

N/A

Address

Block G Jingxinyuan, NO.25 Jia Beiwucun Road, Haidian, Beijing, CHN, 100097

Website

http://www.bohui-tech.com

Beijing Bohui Innovation Biotechnology Co Ltd operates in the medical device industry. The company is focusing on the research and development, production, sales and after-sales services of in vitro diagnostic products. The main products of the company include human element detection system, vitamin D test kits and infectious pathogen detection system. The company serves over 3,000 healthcare institutions in 31 provinces and autonomous regions in China.

Beijing Bohui Innovation Biotechnology Group Co (SZSE:300318) Headlines

No Headlines